AAAAAA
Results:
1-8
|
Results: 8
Authors:
de Wit, R
Roberts, JT
Wilkinson, PM
de Mulder, PHM
Mead, GM
Fossa, SD
Cook, P
de Prijck, L
Stenning, S
Collette, L
Citation: R. De Wit et al., Equivalence of three or four cycles of bleomycin, etoposide, and cisplatinchemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: A randomized study of the European organization for research and treatment of cancer genitourinary tract cancer cooperative group and the medicalresearch council, J CL ONCOL, 19(6), 2001, pp. 1629-1640
Authors:
Sternberg, CN
de Mulder, PHM
Schornagel, JH
Theodore, C
Fossa, SD
van Oosterom, AT
Witjes, F
Spina, M
van Groeningen, CJ
de Balincourt, C
Collette, L
Citation: Cn. Sternberg et al., Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy amd recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for research and treatment of cancerprotocol no. 30924, J CL ONCOL, 19(10), 2001, pp. 2638-2646
Authors:
Collette, L
Sylvester, RJ
Stenning, SP
Fossa, SD
Mead, GM
de Wit, R
de Mulder, PHM
Neymark, N
Lallemand, E
Kaye, SB
Citation: L. Collette et al., Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma, J NAT CANC, 91(10), 1999, pp. 839-846
Authors:
Steffens, MG
Boerman, OC
de Mulder, PHM
Oyen, WJG
Buijs, WCAM
Witjes, JA
van den Broek, WJM
Oosterwijk-Wakka, JC
Debruyne, FMJ
Corstens, FHM
Oosterwijk, E
Citation: Mg. Steffens et al., Phase I radioimmunotherapy of metastatic renal cell carcinoma with I-131-labeled chimeric monoclonal antibody G250, CLIN CANC R, 5(10), 1999, pp. 3268S-3274S
Authors:
de Mulder, PHM
Citation: Phm. De Mulder, The chemotherapy of head and neck cancer, ANTI-CANC D, 10, 1999, pp. S33-S37
Authors:
Planting, AST
Catimel, G
de Mulder, PHM
de Graeff, A
Hoppener, F
Verweij, J
Oster, W
Vermorken, JB
Citation: Ast. Planting et al., Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer, ANN ONCOL, 10(6), 1999, pp. 693-700
Authors:
Rodenhuis, S
de Wit, R
de Mulder, PHM
Keizer, HJ
Sleijfer, DT
Lalisang, RI
Bakker, PJM
Mandjes, I
Kooi, M
de Vries, EGE
Citation: S. Rodenhuis et al., A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission, ANN ONCOL, 10(12), 1999, pp. 1467-1473
Authors:
de Wit, R
Louwerens, M
de Mulder, PHM
Verweij, J
Rodenhuis, S
Schornagel, J
Citation: R. De Wit et al., Management of intermediate-prognosis germ-cell cancer: Results of a phase I/II study of Taxol-BEP, INT J CANC, 83(6), 1999, pp. 831-833
Risultati:
1-8
|